Mackay Shields LLC Bridge Bio Pharma, Inc. Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $1.32 Million - $1.81 Million	-28,300 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $920,802 - $1.2 Million	-16,600 Reduced 36.97%	28,300 $1.74 Million
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $314,716 - $583,102	-8,200 Reduced 15.44%	44,900 $3.19 Million
Q3 2020 Nov 04, 2020	BUY	$27.2 - $42.19 $10,880 - $16,876	400 Added 0.76%	53,100 $1.99 Million
Q2 2020 Jul 31, 2020	BUY	$22.22 - $35.69 $1.17 Million - $1.88 Million	52,700 New	52,700 $1.72 Million

299

171M

10.4M

2.33M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.72B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.